Ingenion Medical Wins Innovate £100,000 UK Grant – Funds to Be Used to Gain a CE Mark for Its CymActive™ Urinary Catheter

A VPN is an essential component of IT security, whether you’re just starting a business or are already up and running. Most business interactions and transactions happen online and VPN

December 18, 2020

Ingenion Medical today, announces it has been awarded nearly £100,000 in grant funding from Innovate UK, the country’s innovation agency.

Ingenion Medical will use the proceeds over the next six months to gain a CE Mark for its CymActive™ urinary catheter, a novel medical device to treat male patients suffering from chronic urinary retention.

Ingenion’s CEO Edward Cappabianca said, “Our technology’s proprietary, a patent-pending magnetic valve lets patients control their urination, without surgery or drugs.”

The device, designed to work with the body’s natural defenses, is expected to reduce the incidence of Catheter-Associated Urinary Tract Infections (CAUTIs), significant contributors to hospital-acquired infections and patient mortality.

Alistair Taylor, Chairman of Ingenion Medical, added, “This is an excellent opportunity for Ingenion to advance technology to benefit urinary retention patients. We anticipate the CymActive™ catheter will be first from our innovation pipeline to launch. We are committed to improving the health and quality of life for men and women suffering from urinary control dysfunctions.”

More

Cofertility Closes Series A Funding, Led by Next Ventures and Offline Ventures, to Revolutionize Fertility and Family Building

April 16, 2025

The funding will be primarily used towards the further development of Cofertility’s proprietary, user-friendly technology platform, a custom-built egg donor database that streamlines the entire egg donation process, from recruitment and matching to cycle coordination. Already this technology has helped improve the Cofertility experience for its members.